Last Updated: May 2020
Author: Division of Maternal and Child Health, Vermont Department of Health
The Title X Family Planning program was enacted in 1970 as Title X of the Public Health Service Act (Public Law 91-572 Population Research and Voluntary Family Planning Programs). Title X is the only federal grant program dedicated solely to providing individuals with comprehensive family planning and related preventive health services. Nationally, Title X-supported clinics provide a number of related preventive health services such as: patient education and counseling; breast and pelvic examinations; breast and cervical cancer screening according to nationally recognized standards of care; sexually transmitted disease (STD) and Human Immunodeficiency Virus (HIV) prevention education, counseling, testing and referral; and pregnancy diagnosis and counseling.
In August 2019, the Vermont Department of Health relinquished Title X federal funding due to the new Federal Rule. The rationale for this change is outlined here. State funds are currently being used to cover formally Title X funded services.
The overarching goal of Vermont's family planning program is to provide high quality clinical family planning and related preventive health services, education, and counseling to Vermonters who would otherwise not have access, with a special focus on low-income and rural populations. Specifically, Vermont's family planning program seeks to:
- Reduce unintended pregnancies in Vermont
- Improve access to a broad range of effective contraceptive methods
- Provide access to emergency contraceptive services
- Reduce sexually transmitted diseases
- Promote healthy relationships, healthy sexual behaviors and strengthen community capacity to promote positive reproductive health
Ensuring access to and encouraging the use of a broad range of effective contraceptive options is a priority of the Health Department's family planning program. Highly effective methods are long acting reversible contraception (LARCs), which include intrauterine devices (IUDs) and subdermal implants.